You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

The International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society grading system has limited prognostic significance in advanced resected pulmonary adenocarcinoma

Westaway, Darin D.*,¶; Toon, Christopher W.*,†,‡,¶; Farzin, Mahtab†,§; Sioson, Loretta†,§; Watson, Nicole; Brady, Peter W.||; Marshman, David||; Mathur, Manu M.||; Gill, Anthony J.*,†,§

Pathology:
doi: 10.1097/PAT.0b013e32836532ae
Anatomical Pathology
Abstract

Introduction: The International Association for the Study of Lung Cancer, the American Thoracic Society and the European Respiratory Society (IASLC/ATS/ERS) system which subclassifies lung adenocarcinoma into five distinct types has been widely adopted. We assessed the prognostic value of subclassifying adenocarcinoma in this way in consecutive patients undergoing surgery.

Methods: All patients at our institution undergoing surgery for lung carcinoma between 2000 and 2010 were identified. The original pathology slides were independently reviewed and reclassified according to the 2011 IASLC/ATS/ERS grading and the American Joint Committee on Cancer (AJCC) 7th edition 2009 staging systems.

Results: We identified 270 patients including 152 with adenocarcinoma histology with long-term follow-up. Using the Kaplan–Meier method, the calculated 5 year survival for each of the adenocarcinoma categories were papillary-predominant 80%, lepidic-predominant 71%, micropapillary-predominant 55%, acinar-predominant 43%, solid-predominant 39% and invasive mucinous adenocarcinoma 38%. The AJCC stage was a very strong predictor of survival (p < 0.001). The IASLC/ATS/ERS subclassification of adenocarcinoma demonstrated a trend as a prognostic marker but failed to reach statistical significance in univariate or multivariate analysis.

Conclusion: Although the IASLC/ATS/ERS classification has been validated by several studies in stage I tumours, further studies of larger cohorts will be required to show prognostic value in unselected lung carcinoma undergoing surgery with curative intent.

Author Information

*Sydney Medical School, Sydney

Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards

HistoPath Pathology, North Ryde

§Departments of Anatomical Pathology, and

||Cardiothoracic Surgery, Royal North Shore Hospital, St Leonards, New South Wales, Australia

these two authors contributed equally

Address for correspondence: Dr A. J. Gill, Department of Anatomical Pathology, Royal North Shore Hospital, Pacific Highway, St Leonards, NSW 2065, Australia. E-mail: affgill@med.usyd.edu.au

Received 27 May, 2013

Revised 13 July, 2013

Accepted 16 July, 2013

© 2013 Royal College of Pathologists of Australasia

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.